Elevations in IL-26 are noted in individuals with rheumatoid arthritis, Behçet’s disease (BD), atopic dermatitis (AD), psoriasis, asthma, and IBD, implicating this cytokine in the development of chronic inflammatory and autoimmune disorders (5–10). This evidence concerns the gene IL26 and Behcet disease.